27.5c is an interesting level that has seen some good action previously, however based on what I highlight below, I wouldn't be surprised if this was breached. An interesting trend line coming in to meet the current price as well.
I see 25c as first support should the sell off gain momentum.
How the MACD, Stochastics and RSI (not on this chart) are currently positioned, it's suggesting that further price weakness is upon us in the near term.
If 25c were to fail, i don't see anything of significance until the 20.5c - 19.5c mark.
Daily -
![]()
Weekly -
![]()
A little concerning on the weekly - 27.5c is a key line in the sand and if it fails the MACD will likely print a negative cross and the stochastics will start their next leg lower.
Playing the FA advocate for a minute, we all know that news can come from the company at anytime to create substantial further interest here, which would likely see the current trend reverse and the topside level at 31c taken out.
So make your own mind up why it is you own shares in ADN and what you are looking to achieve.
ADN CHART, page-4208
-
- There are more pages in this discussion • 1,432 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.5¢ | $92.09K | 5.787M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 0.016 |
43 | 7873041 | 0.015 |
15 | 5136049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 2962774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online